Laura van Dijk

ema pde permitted daily exposure critical effect adverse active pharmaceutical ingredient residual active substances risk pharmaceutical api medicinal product veterinary exposure limit shared facility noael oel shared facility guidelines ich ichq3d health based exposure limits ichq3c(r5) fda cross-contamination